6-(4-Chloro-benzyl)-8-ethyl-5,7-dioxo-5,6,7,8-tetrahydro-[1,3,4]thiadiazolo[3,2-a]pyrimidin-4-ylium

ID: ALA345196

Chembl Id: CHEMBL345196

PubChem CID: 44373265

Max Phase: Preclinical

Molecular Formula: C14H13ClN3O2S+

Molecular Weight: 322.80

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1C(=O)C(Cc2ccc(Cl)cc2)C(=O)[n+]2ncsc21

Standard InChI:  InChI=1S/C14H13ClN3O2S/c1-2-17-12(19)11(7-9-3-5-10(15)6-4-9)13(20)18-14(17)21-8-16-18/h3-6,8,11H,2,7H2,1H3/q+1

Standard InChI Key:  VIHCNYAKSWGBOJ-UHFFFAOYSA-N

Associated Targets(non-human)

PDE1B Heart phosphodiesterase (70 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 322.80Molecular Weight (Monoisotopic): 322.0412AlogP: 1.95#Rotatable Bonds: 3
Polar Surface Area: 54.15Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: 8.62CX Basic pKa: CX LogP: 0.05CX LogD: 0.03
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.64Np Likeness Score: -0.59

References

1. Glennon RA, Rogers ME, Smith JD, El-Said MK, Egle JL..  (1981)  Mesoionic xanthine analogues: phosphodiesterase inhibitory and hypotensive activity.,  24  (6): [PMID:6265635] [10.1021/jm00138a002]

Source